Italian Industry Roadshow Hits The US To Talk Up Its Assets
This article was originally published in Scrip
Executive Summary
The Italian pharmaceutical industry has been busy polishing up its profile abroad. Having taken part in government-sponsored "Invest in Italy" roadshows in Turkey and Japan in October and November 2015, a number of leading Italian companies recently headed to the US to explain why the Italian industry is worth investing in.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.